The Fenway Institute is excited to announce the launch of an innovative new research project called The LITE Study: Leading Innovation for Transgender Women’s Health and Empowerment. The Co-Principal Investigators of this study are Dr. Andrea Wirtz at John’s Hopkins University and Dr. Sari L. Reisner, Research Scientist at The Fenway Institute.
The LITE Study will be the first multi-site cohort of transgender women in the United States and will enroll 1,100 transgender women across Boston, New York, Baltimore-Washington DC, Atlanta and Miami beginning in March 2018. The study aims to enroll 220 participants here in Boston.
Eligible study participants are transgender women and transfeminine people ages 18 and older who speak English (the study will soon accommodate Spanish-speakers), live within the greater Boston area, and are of any HIV status.
All eligible participants will receive $50 for completing the first screening visit, and some may be eligible to earn an additional $400 over the course of two years. Participants in this study will also receive free HIV and STI testing and will have access to exclusive events, raffles, and other offers. In addition to the HIV/STI testing, participants will be asked to complete a survey questionnaire every three months.
Interested in participating? Please call or text Study Coordinator Chiara Draghi or Senior Research Assistant Emily Brown at 857.702.9706 or email [email protected]. Visit our website to find out more.
Want to receive email updates about what’s happening at Fenway Health and AIDS Action? Sign up here.